share_log

ImmunityBio | 8-K: ImmunityBio Reports Third-Quarter 2024 Financial Results

SEC ·  Nov 13, 2024 02:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more